Literature DB >> 31571317

Self-reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe.

A G Hamedani1, A W Willis1,2,3.   

Abstract

BACKGROUND AND
PURPOSE: Visual dysfunction is a non-motor symptom of Parkinson disease (PD), but its prevalence is unknown as population-based data on the epidemiology of visual symptoms in PD are lacking. The objective was to determine the prevalence of visual dysfunction in PD.
METHODS: This was a cross-sectional analysis of data from adults ≥50 years old in the Survey of Health, Ageing and Retirement in Europe (SHARE), a multinational population-based health survey of adults living in one of 27 European countries and Israel. PD diagnosis was self-reported. Impairment in overall, distance or near eyesight was defined as a score of 4 or 5 on a 1-5 scale. Adjusted logistic regression was used to determine the association between PD and self-reported vision.
RESULTS: There were 115 240 age-eligible participants in the SHARE study (mean age 64.3 years, 54% female), of whom 1438 (1.25%) reported a diagnosis of PD. In adjusted logistic regression models, PD was associated with increased odds of impaired overall [odds ratio (OR) 2.67, 95% confidence interval (CI) 1.91-3.72], distance (OR 2.55, 95% CI 2.04-3.19) and near (OR 2.07, 95% CI 1.69-2.55) eyesight. Individuals with PD were also less likely to report having an eye examination within the previous 2 years (OR 0.59, 95% CI 0.38-0.92), but this did not remain statistically significant after adjusting for confounders (OR 0.76, 95% CI 0.47-1.24).
CONCLUSIONS: Visual dysfunction is significantly more common in PD than in the general adult population. Visual symptoms are a potentially under-recognized and under-treated source of reduced quality of life in PD patients that require further attention and study.
© 2019 European Academy of Neurology.

Entities:  

Keywords:  Parkinson disease; epidemiology; non-motor symptoms; vision; visual dysfunction

Mesh:

Year:  2019        PMID: 31571317      PMCID: PMC7012725          DOI: 10.1111/ene.14092

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  25 in total

Review 1.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

Review 2.  Glaucoma as a neurodegenerative disease.

Authors:  Helen V Danesh-Meyer; Leonard A Levin
Journal:  J Neuroophthalmol       Date:  2015-09       Impact factor: 3.042

3.  Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease.

Authors:  Andreas U Bayer; Othmar N Keller; Francis Ferrari; Klaus-Peter Maag
Journal:  Am J Ophthalmol       Date:  2002-01       Impact factor: 5.258

Review 4.  The epidemiology of Parkinson's disease: risk factors and prevention.

Authors:  Alberto Ascherio; Michael A Schwarzschild
Journal:  Lancet Neurol       Date:  2016-10-11       Impact factor: 44.182

Review 5.  Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.

Authors:  Merel S Ekker; Sabine Janssen; Klaus Seppi; Werner Poewe; Nienke M de Vries; Thomas Theelen; Jorik Nonnekes; Bastiaan R Bloem
Journal:  Parkinsonism Relat Disord       Date:  2017-02-21       Impact factor: 4.891

6.  Increased risk of Parkinson disease following a diagnosis of neovascular age-related macular degeneration: a retrospective cohort study.

Authors:  Shiu-Dong Chung; Jau-Der Ho; Chao-Chien Hu; Herng-Ching Lin; Jau-Jiuan Sheu
Journal:  Am J Ophthalmol       Date:  2013-09-29       Impact factor: 5.258

7.  Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes.

Authors:  Ali G Hamedani; Brian L VanderBeek; Allison W Willis
Journal:  Ophthalmic Epidemiol       Date:  2019-05-07       Impact factor: 1.648

Review 8.  Parkinson disease and driving: an evidence-based review.

Authors:  Alexander M Crizzle; Sherrilene Classen; Ergun Y Uc
Journal:  Neurology       Date:  2012-11-13       Impact factor: 9.910

9.  Ophthalmological features of Parkinson disease.

Authors:  Barbara Nowacka; Wojciech Lubinski; Krystyna Honczarenko; Andrzej Potemkowski; Krzysztof Safranow
Journal:  Med Sci Monit       Date:  2014-11-11

Review 10.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more
  6 in total

1.  Nomogram for predicting the 12-year risk of ADL disability among older adults.

Authors:  Weifeng Qi; Zhenhua Yin; Yanping Sun; Lili Wei; Yili Wu
Journal:  Aging Clin Exp Res       Date:  2022-03-17       Impact factor: 3.636

2.  Association of visual impairment with risk for future Parkinson's disease.

Authors:  Zhuoting Zhu; Wenyi Hu; Huan Liao; Zachary Tan; Yifan Chen; Danli Shi; Xianwen Shang; Xueli Zhang; Yu Huang; Honghua Yu; Wei Wang; Mingguang He; Xiaohong Yang
Journal:  EClinicalMedicine       Date:  2021-11-06

3.  Retinal Nerve Fiber Layer Thickness and Associations With Cognitive Impairment in Parkinson's Disease.

Authors:  Zihan Chang; Fen Xie; Hualing Li; Feilan Yuan; Lina Zeng; Lin Shi; Shuzhen Zhu; Xiaohe Lu; Xiaobo Wei; Qing Wang
Journal:  Front Aging Neurosci       Date:  2022-02-10       Impact factor: 5.750

4.  Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.

Authors:  Iris van der Lijn; Gera A de Haan; Famke Huizinga; Fleur E van der Feen; A Wijnand F Rutgers; Catherina Stellingwerf; Teus van Laar; Joost Heutink
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.

Authors:  Iris van der Lijn; Gera A de Haan; Fleur E van der Feen; Famke Huizinga; Anselm B M Fuermaier; Teus van Laar; Joost Heutink
Journal:  PLoS One       Date:  2022-09-14       Impact factor: 3.752

Review 6.  Management of Visual Dysfunction in Patients with Parkinson's Disease.

Authors:  Joseph Savitt; Rachid Aouchiche
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.